Navigation Links
Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
Date:4/25/2013

ecticut-based company like our own, as a financial partner."

About Horizon Technology Finance
Horizon Technology Finance Corporation is a business development company that provides secured loans to development-stage companies backed by established venture capital and private equity firms within the technology, life science, healthcare information and services, and clean-tech industries. The investment objective of Horizon Technology Finance is to maximize total risk-adjusted returns by generating current income from a portfolio of directly originated secured loans as well as capital appreciation from warrants to purchase the equity of portfolio companies. Headquartered in Farmington, Connecticut, with regional offices in Walnut Creek, California and Reston, Virginia, the Company is externally managed by its investment advisor, Horizon Technology Finance Management LLC. Horizon's common stock trades on the NASDAQ Global Select Market under the ticker symbol, "HRZN." In addition, the Company's 7.375% Senior Notes due 2019 trade on the New York Stock Exchange under the ticker symbol "HTF." To learn more, please visit www.horizontechnologyfinancecorp.com.

About New Haven Pharmaceuticals
New Haven Pharmaceuticals Inc. (NHP) is a specialty pharmaceutical company developing proprietary prescription drug products based on proprietary controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience. For more information on NHP, please visit www.newhavenpharma.com, or contact Harry H. Penner, Jr. , Executive Chairman at (203) 676-3676, or email at hpenner@newhavenpharma.com.


'/>"/>

SOURCE Horizon Technology Finance Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Future Horizons in the Global Orthopedics Market
2. Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone)
3. 110+ Health Care Providers Announce Plans To Use Advanced Medical Records Technology To Improve Care For Thousands Of Denver-Area Patients
4. Memorial Hospital of Lafayette County Boosts Patient Safety with Expanded Use of Capnography Technology
5. TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
6. Endexx to attend NAMA Spring Expo for Medical Marijuana Technology Solutions
7. Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE Topical-by-Design Technology
8. iBio Passes Commercial Technology Transfer Milestone
9. Sanovas Launches Next Generation Surgical Imaging Technology
10. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
11. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China ... store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... and policy support, China,s orthopedic ... with total market size rising from 3.28 billion yuan ...
(Date:1/15/2014)... IRVING, Texas , Jan. 15, 2014  Novation, the ... company, awarded several new IT value-added reseller (VAR) national ... with IT goods and services at lower costs. These ... value-added services such as initiative assistance and ongoing IT ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... at ACG Annual Scientific Meeting -, ORLANDO, ... Inc.) and Forest Laboratories,Inc. (NYSE: FRX ) ... Phase,2b study assessing linaclotide,s safety and efficacy in ... Analysis of the data,indicates that once- daily oral ...
... Randomized Placebo-Controlled Phase II Study Shows ... Overall Survival., MOUNTAIN VIEW, California, October 7 ... from the,therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had ... the National,Cancer Institute (NCI) in the US., The ...
Cached Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4
(Date:4/22/2014)... is the standard measurement for assessing glycemic control over ... are typically measured every few months in a laboratory, ... accurately estimates A1c using self-monitored blood glucose (SMBG) readings, ... ( DTT ), a peer-reviewed journal from Mary Ann ... the DTT website at http://www.liebertpub.com/dtt . ...
(Date:4/22/2014)... rein in massive health care spending, a new RAND ... ways to incentivize pharmaceutical companies and device makers to ... examining existing medical technologies and their use, a new ... drugs and medical devices get created in the first ... spending with as little loss of health as possible ...
(Date:4/22/2014)... Nearly 7 in 10 Americans support mandated coverage ... survey by researchers at the University of Michigan Health ... the age of 18 at home, and adults with ... other adults to support universal coverage of birth control ... Journal of the American Medical Association ( ...
(Date:4/22/2014)... is available in German . ... of the University of Vienna and the Medical University of ... shown how double stranded RNA, such as viral genetic information, ... the immune response against viral infection, the protein ADAR1 moves ... modifies viral RNA to inhibit reproduction of the virus. But ...
(Date:4/22/2014)... Washington, DC -- When mothers are exposed to trauma, ... activate a single molecular trigger in brain cells that ... post-traumatic stress disorder and some forms of autism. , ... stressors have impacted the cells of a developing brain. ... exposes herself to alcohol or drug abuse or she ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Life stressors trigger neurological disorders, researchers find 2
... , ... named Capital Confirmation, Inc. its 2010 Best in Business winner for the 1 – 25 ... ... provider of secure audit confirmation services, was named “Best in Business” in the 1 – ...
... ... report assessing best pharmaceutical value-added programs and account managers among key managed care ... ... an ongoing market research project that provides strategic and tactical information to assist ...
... variations might reveal women most at risk, researchers say , ... expression of two common genes trigger cellular changes that can ... researchers adjusted the expression of the genes -- estrogen receptor ... they made in the rodents likely mimic natural variations of ...
... Hundreds ... HCG and how can it help us? , ... May 13, 2010 -- HCG, or human chorionic gonadotropin, is a natural hormone that is found in ... as energy for both the mom and her developing baby. , , , , ,Now, thanks ...
... Non surgical ... ... (GLI) announced a revolutionary hair replication solution recently at their Edina, Mn, office. They utilize ... available. It restores the permanent look of a full head of hair in one day ...
... ... of IT consulting, with many companies providing a variety of high tech services nationwide. ... to offer a spectrum of services to commercial, academic, and governmental IT organizations. , ... South Plainfield, N.J. May 12, 2010 ...
Cached Medicine News:Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 2Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 3Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 2Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 3Health News:Small Changes in Two Genes May Trigger Breast Cancer 2Health News:All About the HCG Drops Diet Program—What it is and Why it Works 2Health News:Good Look Ink Announces Revolutionary Hair Replication Solution 2Health News:Astir IT Solutions Inc. Acquires Inothink Solutions 2
Lorgnette pinhole occluder...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Long handle occluders are approximately 9 inches long....
Medicine Products: